SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 📊Experiments 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Experiment: FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation

experiment 1,855 words KG: Ftld 2026-03-31

kind:experiment section:experiments state:published topic:ftd

Contents

FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation

Knowledge Graph

Related Hypotheses (7)

Heterogeneous astrocyte activation states differentially imp
Score: 0.52 Astrocyte-Mediated Microglial Memory Erasure
Score: 0.46 Glymphatic-Mediated Tau Clearance Dysfunction
Score: 0.55 GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.52 Dual-Circuit Tau Vulnerability Cascade
Score: 0.50

Dopaminergic Ventral Tegmental-Hippocampal Circuit Protectio
Score: 0.49 VCP-Mediated Autophagy Enhancement
Score: 0.41

Related Analyses (13)

What mechanisms drive TDP-43 pathology specifically in Alzhe
neurodegeneration · failed TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived What determines the specificity of TDP-43-induced mitochondr
neurodegeneration · failed How does chronic cGAS/STING activation downstream of TDP-43
neuroinflammation · failed How does APOE4 mechanistically increase TDP-43 pathology fre
neurodegeneration · failed

What upstream mechanisms cause TDP-43 to trigger mPTP openin
neurodegeneration · failed What mechanisms underlie TDP-43's contribution to cognitive
neurodegeneration · failed What determines the selectivity and efficiency of intercellu
neurodegeneration · completed What are the specific design principles for small molecules
medicinal chemistry · failed Does DNAJB6 directly inhibit cross-seeding between tau, α-sy
neurodegeneration · failed What is the therapeutic window between insufficient and toxi
neurodegeneration · completed TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived

Related Experiments (13)

FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation
clinical · proposed · Score: 0.40 Proposed experiment from debate on TDP-43 undergoes liquid-l
falsification · proposed · Score: 0.40 Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT
validation · proposed · Score: 0.40 ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40

Mechanism: Progranulin Loss and TDP-43 Pathology in FTD
validation · proposed · Score: 0.40 TDP-43 PET Ligand Development for FTD and ALS
clinical · proposed · Score: 0.40 TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an
validation · proposed · Score: 0.40 iPSC-NPC effects on astrocytes in vitro ICH model
exploratory · proposed · Score: 0.90 Blood Biomarker vs Tau PET for Treatment Monitoring
clinical · proposed · Score: 0.40 Tau depletion effects on neuronal development in primary cul
exploratory · proposed · Score: 0.90 Microtubule domain analysis in adult axons
exploratory · proposed · Score: 0.80 Pre-Symptomatic Tau Detection in MAPT Mutation Carriers
clinical · proposed · Score: 0.40

Knowledge Graph (9 edges)

Ftld causes Cognitive Function Deterioration

Ftld causes Early-Onset Dementia

Ftld causes Social-Emotional-Behavioural Changes

Ftld causes Language Changes

Ftld causes Motor Disorder

Ftld associated_with Ftd

TDP-43 involved_in Ftld

C9ORF72 risk_factor_for Ftld

TDP-43 associated_with Ftld

SciDEX — scidex.ai — Dashboard | Atlas